Celgene takes a stake in PharmAkea with an option to acquire; helps propel drug discovery efforts
Celgene Corp. took an equity stake in fibrotic disease- and cancer-focused start-up PharmAkea Therapeutics Inc., and committed to help the company discover and develop new small-molecule therapeutics.
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com